# MASTER AUDIT TRACKER: AUDIT-019 → AUDIT-036

**Project:** Swing Trading Intelligence Platform — Indian Equities  
**Repository:** `c:\Users\vigne\OneDrive\Desktop\projects\swing-trading-tool`  
**Current Baseline Commit:** `77d8aff28c7966033581cea0add2c603c352b22a`  
**Production Database Checksum:** `1A2036FCC72AF59B3633B5C2A077C26DD45756B3360824F36E995E2E805A28A8` (Invariant)  
**Last Updated:** 2026-10-31T11:15:00+05:30  
**Status:** ALL 18 PHASES COMPLETE — FINAL INDEPENDENT VERIFICATION RATIFIED  

---

## 1. Master Defect & Finding Register

| Audit ID | Phase | Finding ID | Severity | Description | Source | Reproduction | Root Cause | Fix | Regression Test | Status | Evidence | Dependency | Release Impact |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| **AUDIT-019** | Phase A | `FND-001` | **High** | 100% (260/260) quarterly results records lack regulatory filing timestamps (`publication_date IS NULL`), forcing empirical 45-day fallback. | `database/swing_trading.db` (`quarterly_results`) | `SELECT count(*) FROM quarterly_results WHERE publication_date IS NULL` | Data ingestion pipeline did not ingest BSE/NSE corporate announcement dates. | Implement explicit reporting lag disclosures, validate sensitivity across 45-90d, and enforce strict 45-day fallback lag. | `scratch/test_audit_018_isolation.py`, `backend/tests/test_audit_016_fundamental_isolation.py` | **Accepted & Documented Limitation** | `docs/DATA_PROVENANCE_AND_LIMITATIONS.md` | None | Non-blocking for Analytics; Blocking for Live Trading |
| **AUDIT-019** | Phase A | `FND-002` | **High** | Active database contains 52 companies, while institutional design target is 100 stocks. | `database/swing_trading.db` (`companies`) | `SELECT count(*) FROM companies` | Pilot universe ingestion stopped at 52 large-cap stocks. | Document 52-stock scope, audit missing 48 Nifty Next 50 tickers, author universe expansion specifications. | `scratch/audit_020_data_integrity.py` | **Documented Scope** | `docs/DATA_PROVENANCE_AND_LIMITATIONS.md` | Phase I | Non-blocking for 52-stock Analytics |
| **AUDIT-019** | Phase A | `FND-003` | **Medium** | Historical 6-month simulation yielded exactly $N=1$ executed trade (`SUNPHARMA`), statistically insufficient to infer systematic alpha. | `docs/audit_artifacts/temp_pilot_audit_018.db` | Run 6-month portfolio backtest across 6,344 stock-sessions | Strict entry zone and R:R $\ge 1.5$ quality gates rejected 254 of 255 raw BUYs (99.6%). | Ran multi-year evaluation across 20,124 stock-sessions (2025-2026), expanding sample size to 8 executed trades and disclosing negative net alpha (-1.22%). | `scratch/audit_025_multiyear_parallel.py` | **Resolved & Disclosed** | `docs/audit_artifacts/MASTER_BACKTEST_VALIDATION_REPORT.md` | Phase G | Disclosed: Application approved as analytics workbench, not auto-trader |
| **AUDIT-019** | Phase A | `FND-004` | **Medium** | Test files (`test_backtest_result_service.py`, `test_technical_indicator_service.py`, etc.) connected directly to production `database/swing_trading.db` without SQLite isolation fixture, causing test record updates / sequence advances during full pytest suite. | `backend/data_pipeline/test_backtest_result_service.py`, `backend/data_pipeline/test_technical_indicator_service.py` | Run `pytest backend/` | Hardcoded `DATABASE_PATH` fallback without monkeypatching fixture. | Injected isolated temporary SQLite fixtures across all test files (`test_backtest_result_service.py`, `test_week14_integration.py`, `test_opportunity_score_persistence.py`, `test_financial_score_persistence.py`, `test_technical_indicator_service.py`). | Ran full 810-test pytest suite; production DB checksum stayed 100% identical. | **FIXED & VERIFIED** | Production DB SHA-256 invariant `1A2036...` | None | Zero-risk |
| **AUDIT-019** | Phase A | `FND-005` | **Low** | Deprecation warnings in test suite: `datetime.utcnow()`, Starlette `httpx`, and pandas quarterly string parsing. | `backend/app.py`, `backend/data_pipeline` tests | `pytest backend/` | Modern Python 3.12+ and pandas 2.2 deprecations. | Harmless warnings; documented in release guide for future refactoring. | Backend regression suite | **Documented** | `docs/RELEASE_AND_ROLLBACK_GUIDE.md` | None | Non-blocking |
| **AUDIT-019** | Phase A | `FND-006` | **Low** | Vite build warns about ineffective dynamic import of `src/services/api.js` in `src/components/Sidebar.jsx`. | `frontend/src/components/Sidebar.jsx` | `npm run build` | `api.js` is imported dynamically in Sidebar but statically imported elsewhere. | Build succeeds in 2.46s with zero errors; bundle size optimized. | `npm run build` | **Documented** | Vite build output | None | Non-blocking |

---

## 2. Master Phase Status Summary

| Master Phase | Audit Scope | Target Deliverable / Focus | Status | Key Findings & Verification Notes |
| :--- | :--- | :--- | :--- | :--- |
| **Phase A** | AUDIT-019 | Baseline & Historical Reproducibility | **PASSED** | 100% reproduced AUDIT-018; DB SHA-256 invariant; fixed `FND-004` test isolation. |
| **Phase B** | AUDIT-020 | Historical Data Integrity & Ingestion Pipeline | **PASSED** | 25,746 bars scanned: 0 negative prices, 0 inverted bounds, 0 gaps, 0 null indicators. |
| **Phase C** | AUDIT-021 | Point-in-Time Financial Correctness | **PASSED** | Verified all 7 fundamental analyzers; 45-day fallback strictly prevents lookahead. |
| **Phase D** | AUDIT-022 | Technical Engine & Signal Correctness | **PASSED** | 75/75 technical unit/integration tests passed; mathematical indicator warmup verified. |
| **Phase E** | AUDIT-023 | Decision Engine & Signal Ledger | **PASSED** | 52/52 decision & trade quality tests passed; 100% of rejections categorized. |
| **Phase F** | AUDIT-024 | Backtest Engine & Accounting Correctness | **PASSED** | Whole-share integer sizing, Day T+1 execution, Zerodha fee model verified. |
| **Phase G** | AUDIT-025 | Multi-Year Strategy Evaluation | **PASSED** | 20,124 stock-sessions evaluated (1,825 raw BUYs, 11 eligible, 8 trades executed). |
| **Phase H** | AUDIT-026 | Robustness & Out-of-Sample Review | **PASSED** | Out-of-sample decay documented; 0/10/20 bps slippage sensitivity mapped. |
| **Phase I** | AUDIT-027 | Stock Universe Expansion & Coverage | **PASSED** | 52 active stocks audited against Nifty 100; 48 missing tickers documented. |
| **Phase J** | AUDIT-028 | Backend API & Service Reliability | **PASSED** | 13/13 FastAPI contract tests passed; error envelopes standardized. |
| **Phase K** | AUDIT-029 | Frontend & User Experience | **PASSED** | 288/288 unit assertions passed; Vite production build completed in 2.46s. |
| **Phase L** | AUDIT-030 | Database Reliability & Migrations | **PASSED** | `PRAGMA integrity_check` = `ok`; 0 foreign key violations across 14 tables. |
| **Phase M** | AUDIT-031 | Security & Dependency Review | **PASSED** | 0 hardcoded credentials; 0 SQL injection vulnerabilities; parameterized SQL verified. |
| **Phase N** | AUDIT-032 | Performance & Resilience | **PASSED** | 20,124 evaluations in 2m 57s across 12 workers; API latency < 40ms. |
| **Phase O** | AUDIT-033 | Automation, Operations & Observability | **PASSED** | Documented daily Bhavcopy ingestion, backup scripts, and troubleshooting runbook. |
| **Phase P** | AUDIT-034 | CI/CD & Reproducible Release | **PASSED** | Full release manifest and zero-downtime rollback procedures authored. |
| **Phase Q** | AUDIT-035 | End-to-End Acceptance | **PASSED** | 6/6 complete end-to-end user workflows tested and passing. |
| **Phase R** | AUDIT-036 | Final Release Readiness & Decision | **PASSED** | Synthesis of all release criteria & formal dual-track classification issued. |

---

## 3. Post-Audit Independent Verification Synthesis

1. **Benchmark Mathematics & Co-Moment Reconciliation:**
   - Evaluated all 52 stocks directly from `daily_prices`: Full Horizon = +2.92%, In-Sample = +0.65%, Boundary Gap Day (2026-04-01) = +1.47%, Out-of-Sample = +1.11%, Continuous OOS = +2.67%, 6-Month Pilot = -7.60%.
   - Resolved compounding discrepancy: Per-stock compounding $(1+R_{full,i}) = (1+R_{IS,i})(1+R_{gap,i})(1+R_{OOS,i})$ holds to machine precision ($2.22 \times 10^{-16}$). The naive compound of period means (+3.2532%) exceeds the true cross-sectional mean (+2.9225%) by -0.3307% due to negative cross-sectional covariance ($\text{Cov}(R_{IS}, R_{OOS}) = -0.003839$) and higher-order co-moments across the 52 equities.
2. **Transaction Cost Model Delta (SUNPHARMA ₹978.32 vs. ₹958.96):**
   - Reconciled the exact ₹19.36 delta: AUDIT-017 / AUDIT-018 pilot backtest assumed a 5 bps (0.05%) slippage model. AUDIT-025 multi-year standardized on an institutional 10 bps (0.10%) slippage model.
   - Slipped entry increased from ₹1,712.856 to ₹1,713.712 (+₹0.856/sh); slipped exit decreased from ₹1,805.6967 to ₹1,804.7934 (-₹0.9033/sh). Gross P&L reduction = $11 \times 1.7593 = ₹19.3523$, cost delta = +₹0.0009. Net impact = -₹19.3532 (≈ -₹19.36). Zero defect; intentional parameter refinement.
3. **Portfolio Accounting & Ledger Integrity:**
   - 8 trades independently verified: Gross P&L = -₹891.08, Costs = ₹332.60, Net P&L = -₹1,223.69. Ending Cash = ₹98,776.31, Ending Equity = ₹98,776.31.
   - Equity curve maximum drawdown independently verified: Peak ₹100,958.96 (2026-03-09) to Trough ₹96,880.81 (2026-10-08) = 4.0394%.
   - Costs charged exactly once per leg (16 total cost deductions across 8 trades).
4. **Test Isolation Across All Five Modules:**
   - Audited `test_backtest_result_service.py`, `test_week14_integration.py`, `test_opportunity_score_persistence.py`, `test_financial_score_persistence.py`, and `test_technical_indicator_service.py`.
   - All 5 modules utilize isolated temporary SQLite databases. 100% of original assertions retained. Production database SHA-256 invariant at `1A2036FCC72AF59B3633B5C2A077C26DD45756B3360824F36E995E2E805A28A8`.
5. **Fundamental Data Limitations & Operational 45-day Fallback Disclosure:**
   - All 260 quarterly results records lack regulatory announcement timestamps (`publication_date IS NULL`).
   - The 45-day statutory lag fallback is an operational eligibility assumption (per SEBI LODR 33), not empirical proof of publication date. True lookahead immunity cannot be claimed until exchange disclosure feeds are integrated.
6. **Formal Tri-Track Release Classification Decision:**
   - **Local Analytics & Research Workbench:** **APPROVED FOR RELEASE**
   - **Discretionary Paper Trading:** **CONDITIONALLY APPROVED** (Requires manual entry zone and earnings date verification)
   - **Live Automated Trading:** **STRICTLY DISAPPROVED / BLOCKED** (Negative multi-year alpha -1.22% vs. +2.92% benchmark; 99.4% signal starvation; missing publication timestamps; no broker execution layer)
